Jason Lettmann Net Worth & Insider Trades

Jason Lettmann - Director, Alx Oncology Holdings Inc

As of June 16, 2022

What is Jason Lettmann's Net Worth?

The current estimated net worth of Alx Oncology Holdings Inc's Director, Jason Lettmann, is estimated to be about $63.77M . Jason Lettmann owns about 393,176 units of Alx Oncology Holdings Inc common stock. In the last 2 years at Alx Oncology Holdings Inc, Jason Lettmann has sold an estimated value of $13.6M worth.

What is Jason Lettmann's Past Insider Trading?

Jason Lettmann's largest purchase order was 4,179,875 units , worth over $7.6M on July 21, 2020. Jason Lettmann's largest sale order was 325,377 units , worth over $8.9M on December 15, 2021. In total, Jason Lettmann has made about 6 transactions over 2 years of their time at Alx Oncology Holdings Inc. Jason Lettmann usually trades in July, June and December, with the busiest year in 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jason Lettmann's' Mailing Address?

  • Mailing address is C/o Ra Pharmaceuticals, Inc. 87 Cambridgepark Drive Cambridge MA 02140 MA

Alx Oncology Holdings Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Bonus
Other Compensation
Total
Jaume Pons, Ph.D. 2020 $487,708 $5,953,964 $292,759 $500,000 - $7,234,431
Jaume Pons, Ph.D. 2019 $422,300 $134,002 $147,900 - - $704,202
Peter Garcia 2020 $416,818 $2,006,792 $200,837 $200,000 - $2,824,447
Sophia Randolph, M.D., Ph.D. 2020 $397,588 $1,818,862 $190,915 $350,000 - $2,757,365
Sophia Randolph, M.D., Ph.D. 2019 $351,100 $40,834 $105,400 - - $497,334
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1810182/000119312521140336/d170160ddef14a.htm

What are Alx Oncology Holdings Inc's Past Insider Trades?

Alx Oncology Holdings Inc's most recent insider trade came on December 15, 2021 by Jason Lettmann who sold 325,377 units worth $8.9M . In the last year, insiders at Alx Oncology Holdings Inc have sold an estimated value of $39.46M and bought an estimated value of $87M worth of shares. Insider trading is most common in July, with the busiest year in 2021. The most active traders at the company are Jaume Pons, President & CEO,  Sophia Randolph, Chief Medical Officer,  and Peter Garcia, Chief Financial Officer .

ALX ONCOLOGY HOLDINGS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1